Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 2/20 | 0.53 |
| ▸ | KDM1A | O60341 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 5/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22849632 | 1.00 | AGXT (0.53) | AGXTKDM1AMAPK1KDM4ETDP1 | |
| SCHEMBL29519635 | 0.85 | AGXT (0.57) | AGXTKDM1AMAPK1KDM4ETDP1 | |
| SCHEMBL114254 | 0.85 | AGXT (0.57) | AGXTKDM1AMAPK1KDM4ETDP1 | |
| SCHEMBL14764488 | 0.84 | CYP2A6 (0.46) | KDM1ATDP1RAB9ANPC1CYP1A2 | |
| SCHEMBL14764486 | 0.82 | KDM1A (0.40) | AGXTKDM1AMAPK1RAB9ANPC1 | |
| SCHEMBL29670114 | 0.81 | LMNA (0.63) | AGXTKDM1AMAPK1KDM4ETDP1 | |
| SCHEMBL1435391 | 0.81 | AGXT (0.58) | AGXTKDM1AMAPK1KDM4ETDP1 | |
| SCHEMBL7973999 | 0.81 | LMNA (0.63) | AGXTKDM1AMAPK1KDM4ETDP1 | |
| SCHEMBL11831663 | 0.81 | AGXT (0.58) | AGXTKDM1AMAPK1KDM4ETDP1 | |
| SCHEMBL22838174 | 0.80 | CYP1A2 (0.52) | AGXTKDM1AMAPK1KDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11306091-B2 | Process for producing fluorinated compounds using alcohol solvent having unsaturated hydrocarbon | FUTURECHEM CO., LTD (KR) | 2022-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11306091-B2 | Process for producing fluorinated compounds using alcohol solvent having unsaturated hydrocarbon | FASN, CYP2F1, FDFT1 | AGXT 2684/4885KDM1A 2250/4885MAPK1 1383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.